Akebia to Host Conference Call on November 8th at 8:00 a.m. ET
CAMBRIDGE, Mass., Oct. 31,
2023 /PRNewswire/ -- Akebia Therapeutics®,
Inc. (Nasdaq: AKBA) today announced plans to release its
financial results for the third quarter ended September 30, 2023 on Wednesday, November 8, 2023, prior to the open of
Akebia will host a conference call on Wednesday, November 8 at 8:00 a.m. ET to discuss its financial results and
recent business highlights. To access the call by phone, please
click on this Registration Link and you will be provided with dial
in details. To avoid delays, we encourage dialing into the
conference call fifteen minutes ahead of the scheduled start
A live webcast of the conference call will be available via the
Investors section of Akebia's website at: https://ir.akebia.com/.
An online archive of the webcast can be accessed via the Investors
section of Akebia's website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. Akebia was
founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
View original content to download
SOURCE Akebia Therapeutics